| Code | CSB-RA011580MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to BT063, targeting interleukin-10 (IL-10), a potent immunoregulatory cytokine with broad anti-inflammatory properties. IL-10 is primarily produced by activated immune cells, including T cells, B cells, monocytes, and macrophages, and functions to suppress excessive immune responses by inhibiting pro-inflammatory cytokine production and antigen presentation. This cytokine plays a critical role in maintaining immune homeostasis and preventing inflammatory tissue damage. Dysregulation of IL-10 signaling has been implicated in various pathological conditions, including autoimmune diseases, chronic infections, inflammatory bowel disease, and cancer, where it can contribute to immune evasion by tumor cells.
BT063 serves as the reference antibody for this biosimilar product, providing researchers with a reliable tool for investigating IL-10-mediated pathways and therapeutic interventions. This antibody is valuable for studies exploring immune regulation, cytokine signaling networks, tumor immunology, and inflammatory disease mechanisms. It enables researchers to examine IL-10's complex roles in both protective immunity and pathological immune suppression across diverse experimental systems.
There are currently no reviews for this product.